Overview

Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Primary Objective: To assess the safety and tolerability of SAR113945 in Japanese patients with knee osteoarthritis after ascending single intra-articular doses Secondary Objective: To assess the pharmacokinetics of SAR113945 in Japanese patients with knee osteoarthritis after ascending single intra-articular doses
Phase:
Phase 1
Details
Lead Sponsor:
Sanofi